CHARGE Study: CHoice ARchitecture Genetic tEsting

Description

CHARGE is a hybrid type I feasibility study to compare a choice architecture intervention for cascade genetic testing to usual care.

Conditions

Hereditary Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

CHARGE is a hybrid type I feasibility study to compare a choice architecture intervention for cascade genetic testing to usual care.

CHARGE: CHOICE ARCHITECTURE IN GENETIC TESTING

CHARGE Study: CHoice ARchitecture Genetic tEsting

Condition
Hereditary Cancer
Intervention / Treatment

-

Contacts and Locations

Dallas

UT Southwestern Medical Center, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Have a newly reported pathogenic or likely pathogenic variant in one or more of the following genes: APC, ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, MLH1, MSH2, MSH6, PMS2, PTEN, TP53
  • * 18 years of age or older
  • * English fluency
  • * Have at least 1 adult living genetically related relative who resides in Texas
  • * Referred for genetic testing by a relative with a pathogenic variant
  • * Unwilling to be randomized to a study arm

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Texas Southwestern Medical Center,

Sukh Makhnoon, PhD, MS, PRINCIPAL_INVESTIGATOR, UT Southwestern Medical Center

Study Record Dates

2025-08